372 related articles for article (PubMed ID: 18450871)
41. Aspergillosis of the central nervous system: a catastrophic opportunistic infection.
Pongbhaesaj P; Dejthevaporn C; Tunlayadechanont S; Witoonpanich R; Sungkanuparph S; Vibhagool A
Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):119-25. PubMed ID: 15272754
[TBL] [Abstract][Full Text] [Related]
42. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
[TBL] [Abstract][Full Text] [Related]
43. [Therapy of invasive aspergillosis with itraconazole: our own experiences and review of the literature].
Kreisel W
Mycoses; 1994; 37 Suppl 2():42-51. PubMed ID: 7609743
[TBL] [Abstract][Full Text] [Related]
44. Epidemiology of invasive fungal infections in neonates and children.
Steinbach WJ
Clin Microbiol Infect; 2010 Sep; 16(9):1321-7. PubMed ID: 20840541
[TBL] [Abstract][Full Text] [Related]
45. Pulmonary aspergillosis in solid organ transplant patients: a report from Iran.
Marjani M; Tabarsi P; Najafizadeh K; Rashid Farokhi F; Sharifkashani B; Motahari S; Abbasi A; Masjedi MR; Mansouri D
Transplant Proc; 2008 Dec; 40(10):3663-7. PubMed ID: 19100461
[TBL] [Abstract][Full Text] [Related]
46. Invasive mold infections in iatrogenically immunocompromised children: an eight-yr review.
Al-Rezqi A; Hawkes M; Doyle J; Richardson SE; Allen U
Pediatr Transplant; 2009 Aug; 13(5):545-52. PubMed ID: 18992060
[TBL] [Abstract][Full Text] [Related]
47. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
48. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
[TBL] [Abstract][Full Text] [Related]
49. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes.
Parody R; Martino R; Sánchez F; Subirá M; Hidalgo A; Sierra J
Am J Hematol; 2009 Sep; 84(9):571-8. PubMed ID: 19676118
[TBL] [Abstract][Full Text] [Related]
50. Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.
Babor F; Schuster F; Mackenzie C; Meisel R; Schaper J; Sabir H; Siepermann M; Wessalowski R; Janßen G; Borkhardt A; Laws HJ
Klin Padiatr; 2012 Apr; 224(3):160-5. PubMed ID: 22504775
[TBL] [Abstract][Full Text] [Related]
51. Results of a multicenter retrospective study of a combined medical and surgical approach to pulmonary aspergillosis in pediatric neutropenic patients.
Cesaro S; Cecchetto G; De Corti F; Dodero P; Giacchino M; Caviglia I; Fagioli F; Livadiotti S; Salin F; Caselli D; Castagnola E
Pediatr Blood Cancer; 2007 Dec; 49(7):909-13. PubMed ID: 17154183
[TBL] [Abstract][Full Text] [Related]
52. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A;
Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151
[TBL] [Abstract][Full Text] [Related]
53. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
[TBL] [Abstract][Full Text] [Related]
54. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.
Barnes RA; White PL; Bygrave C; Evans N; Healy B; Kell J
J Clin Pathol; 2009 Jan; 62(1):64-9. PubMed ID: 19103864
[TBL] [Abstract][Full Text] [Related]
55. [Diagnosis and treatment of invasive aspergillosis infection following orthotopic liver transplantation].
Yi SH; Chen GH; Lu MQ; Yang Y; Cai CJ; Xu C; Li H; Wang GS; Yi HM
Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(13):885-8. PubMed ID: 17067477
[TBL] [Abstract][Full Text] [Related]
56. What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience.
Simoneau E; Kelly M; Labbe AC; Roy J; Laverdière M
Bone Marrow Transplant; 2005 Feb; 35(3):303-6. PubMed ID: 15580278
[TBL] [Abstract][Full Text] [Related]
57. Invasive aspergillosis in the recipients of liver retransplantation.
Singh N; Pruett TL; Houston S; Muñoz P; Cacciarelli TV; Wagener MM; Husain S
Liver Transpl; 2006 Aug; 12(8):1205-9. PubMed ID: 16598780
[TBL] [Abstract][Full Text] [Related]
58. Invasive aspergillosis in children with hematological malignancies.
Ozen M; Dündar NO
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):299-306. PubMed ID: 21417869
[TBL] [Abstract][Full Text] [Related]
59. Serial Aspergillus antigen monitoring in pediatric bone marrow transplant patients.
Baker C
J Pediatr Oncol Nurs; 2006; 23(6):300-4. PubMed ID: 17035619
[TBL] [Abstract][Full Text] [Related]
60. Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy.
Lass-Flörl C
Expert Rev Anti Infect Ther; 2010 Feb; 8(2):127-35. PubMed ID: 20109043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
